Claudia Lengerke

40PUBLICATIONS
164CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)HaematologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Aug 12, 2026
Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve.

|Feb 24, 2026
Predictive capacity of peritransplant measurable residual disease thresholds in NPM1-mutant acute myeloid leukemia.

Jan Christian Schroeder, Friederike Schwartz, Judith Metzdorf

|Nov 25, 2025
Predictive capacity of peritransplant measurable residual disease thresholds in NPM1-mutant acute myeloid leukemia.

Jan Christian Schroeder, Friederike Schwartz, Judith Metzdorf

|Sep 30, 2025
Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL.

Malte Roerden, Luca Hensen, Britta Besemer

|Jul 29, 2025
Casein kinase 1α essentially regulates thrombopoiesis by driving megakaryocyte maturation and cytoskeleton organization.

Ferdinand Kollotzek, Kristina Mott, Melina Fischer

|Apr 14, 2025
Trends in Overall Survival in Lung Adenocarcinoma with EGFR Mutation, KRAS Mutation, or No Mutation.

Martin Faehling, Sabine Fallscheer, Birgit Schwenk

Pageof 7

Frequent Collaborators

13 joint publications

Wolfgang Bethge

5 joint publications

Jan Schröder

5 joint publications

Martina Konantz

3 joint publications

Friederike Schwartz